Anti-neutrophil cytoplasmic antibody (ANCA) levels directed against proteinase-3 and myeloperoxidase are helpful in predicting disease relapse in ANCA-associated small-vessel vasculitis.
Stegeman
Coen A
CA
Department of Nephrology, University Medical Centre Groningen, Groningen, The Netherlands. c.a.stegeman@int.azg.nl
D019268:Antibodies, Antineutrophil Cytoplasmic / Q000032:analysis* / Q000276:immunology*; D005500:Follow-Up Studies; D005544:Forecasting; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D053146:Myeloblastin; D009195:Peroxidase / Q000276:immunology*; D012008:Recurrence; D012697:Serine Endopeptidases / Q000276:immunology*; D017211:Treatment Failure; D014657:Vasculitis / Q000188:drug therapy / Q000276:immunology* / Q000503:physiopathology
D019268:Antibodies, Antineutrophil Cytoplasmic; D007166:Immunosuppressive Agents; D009195:Peroxidase; D012697:Serine Endopeptidases; D053146:Myeloblastin